Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Invest Ophthalmol Vis Sci ; 42(10): 2173-8, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11527927

RESUMO

PURPOSE: To characterize the pathologic features in retina, optic nerve, and extraocular muscle of mitochondrial superoxide dismutase (Sod2)-deficient mice, a model of increased mitochondrial production of reactive oxygen species. METHODS: Morphometric and ultrastructural study of eyes of 43 homozygous sod2(tm1Cje-/-) mice and wild-type control animals. For retinal morphometric analysis, 32 manganese 5,10,15,20-tetrakis (4-benzoic acid) porphyrin (MnTBAP)-treated animals aged either 9 to 10 days or 20 to 21 days were studied. Ultrastructural examination was performed on tissue from the treated animals, and 11 additional untreated mutant and control animals. RESULTS: In treated Sod2-deficient animals, the photoreceptor layer was thinner centrally at 9 to 10 days than in control animals (mean 8.8 vs. 14.7 microm). By 20 to 21 days, all retinal layers apart from the outer nuclear layer and retinal pigment epithelium (RPE) were thinner centrally in mutant animals (total retinal thickness, 233.2 vs. 272.6 microm; combined nerve fiber layer, ganglion cell layer, and inner plexiform layer, 86.2 vs. 103.4 microm; inner nuclear layer, 51.8 vs. 60.3 microm; photoreceptors, 26.7 vs. 35.6 microm). Optic nerve cross-sectional area was less in 20- to 21-day-old treated Sod2-deficient animals than in control animals. Mitochondrial morphologic abnormalities (swelling, pale matrix, and disorganized cristae) were found predominantly in older mutant animals' (16 and 20 to 21 days) RPE and in extraocular muscle of a 16-day-old untreated mutant. CONCLUSIONS: In sod2(tm1Cje-/-) mice, there is relative progressive retinal thinning, with particular involvement of the inner retinal layers and an early effect on the photoreceptor layer, as well as mitochondrial morphologic abnormalities, all consistent with mitochondrial disease.


Assuntos
Mitocôndrias/enzimologia , Músculos Oculomotores/ultraestrutura , Doenças do Nervo Óptico/patologia , Doenças Retinianas/patologia , Superóxido Dismutase/deficiência , Animais , Sequestradores de Radicais Livres/uso terapêutico , Metaloporfirinas/uso terapêutico , Camundongos , Camundongos Mutantes , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/patologia , Mitocôndrias Musculares/efeitos dos fármacos , Mitocôndrias Musculares/enzimologia , Mitocôndrias Musculares/ultraestrutura , Músculos Oculomotores/efeitos dos fármacos , Músculos Oculomotores/enzimologia , Doenças do Nervo Óptico/enzimologia , Doenças do Nervo Óptico/etiologia , Doenças do Nervo Óptico/prevenção & controle , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo , Doenças Retinianas/enzimologia , Doenças Retinianas/etiologia , Doenças Retinianas/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...